Vimovo is a prescription medication that combines two active ingredients: naproxen and esomeprazole magnesium. Naproxen belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs), which are used to relieve pain and reduce inflammation from various conditions such as arthritis, menstrual cramps, and other musculoskeletal disorders. Esomeprazole magnesium is a proton pump inhibitor (PPI) that reduces the amount of acid produced in the stomach. The inclusion of esomeprazole in Vimovo is intended to protect the stomach lining from the potential damage that can be caused by naproxen, especially with long-term use. This combination makes Vimovo particularly useful for patients who require NSAID treatment but are at risk of developing gastric ulcers or have a history of gastrointestinal issues. It is typically prescribed for the treatment of symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, among other conditions, while aiming to minimize the gastrointestinal side effects associated with NSAID therapy.